Study to Test the Combination of Fulvestrant With Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors
Clinical trial NCT06663072 · RECRUITING
Trial details
- NCT number
- NCT06663072
- Sponsor
- University of Chicago
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-13
- Primary completion
- 2026-11-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.